To further validate GILncSig expression in HCC, GSE76427 was used to measure the expression level of GILncSig, and the results showed that compared with PANT group, the AC026803.2, RHPN1-AS1, LINC00221, AL031058.1, ZFPM2-AS1, and THORLNC levels were significantly higher in the HCC group, however, the CR936218.2 and AL359915.1 levels were significantly lower in the HCC group (Figures 8A,C). Here, ZFPM2 is linked to hepatocellular carcinoma.